{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-280656","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2023-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.470879+00:00","generated_at":"2026-06-07T23:43:55.364131+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"ResMed amends bylaws for universal proxy rules; annual meeting results filed","bullets":["Board adopted amended bylaws on Nov 17, 2023, addressing SEC universal proxy rules (Rule 14a-19) and restricting proxy card color.","Stockholders elected all 10 director nominees; votes ranged from 91.5M (Sulpizio) to 102.5M (De Witte).","KPMG ratified as auditor for FY ending June 30, 2024: 105.1M for, 6.0M against.","Say-on-pay approved on advisory basis: 84.3M for, 19.6M against; future say-on-pay votes set to annual.","Bylaw amendments include technical, ministerial, and DGCL-alignment updates."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-280656","json":"https://secwatch.observer/filing/0001193125-23-280656.json","markdown":"https://secwatch.observer/filing/0001193125-23-280656.md","text":"https://secwatch.observer/filing/0001193125-23-280656.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/0001193125-23-280656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/d892007d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T23:43:55.364131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26b58f688cb00a8104d46377a08934a1b9c4ed5f","claim":"RESMED INC: Amended and restated bylaws to address universal proxy rules, proxy card color requirement, and other updates (effective 2023-11-17).","evidence_excerpt":"On November 17, 2023, the Board of Directors (the “Board”) of ResMed Inc., a Delaware corporation (the “Company”) approved and adopted an amendment and restatement of the Company’s amended and restated bylaws (as so amended, the “Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/0001193125-23-280656-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-11-17"}],"fact_type":"governance_change"},{"claim_id":"56de0c25b33bc6891e88f49070c6faf31dd16cdb","claim":"RESMED INC shareholders approved Approve, on an advisory basis, the compensation of our named executive officers at the 2023-11-16 meeting.","evidence_excerpt":"Item of business 3: Approve, on an advisory basis, the compensation of our named executive officers, as disclosed in our proxy statement (“say-on-pay”). 84,318,661 19,649,791 77,972 7,126,855","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/0001193125-23-280656-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-16"}],"fact_type":"shareholder_vote"},{"claim_id":"59455284c9bbd20a428bf87e43cc8aa77a5ba1b1","claim":"RESMED INC shareholders approved Approve, on an advisory basis, the frequency of future say-on-pay votes on an annual basis at the 2023-11-16 meeting.","evidence_excerpt":"Item of business 4: Approve, on an advisory basis, the frequency of future say-on-pay votes. 101,600,575 463,611 948,607 1,033,631","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/0001193125-23-280656-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-16"}],"fact_type":"shareholder_vote"},{"claim_id":"8df544d7a2af3f69fae976b272153d7df1f1ea04","claim":"RESMED INC shareholders approved Ratify selection of KPMG LLP as independent registered public accounting firm for fiscal year ending June 30, 2024 at the 2023-11-16 meeting.","evidence_excerpt":"Item of business 2: Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2024. 105,125,513 5,995,541 52,225","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/0001193125-23-280656-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-16"}],"fact_type":"shareholder_vote"},{"claim_id":"dc82b85b2ea6b42ac2ceb0c14497499af05d03c4","claim":"RESMED INC shareholders approved Election of ten directors named below at the 2023-11-16 meeting.","evidence_excerpt":"Item 5.07. Submission of Matters to a Vote of Security Holders. On November 16, 2023, at our annual meeting of stockholders, our stockholders (1) elected the ten nominees listed below to serve on our board of directors; (2) ratified the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2024; and (3) approved, on an advisory basis, the compensation of our named executive officers (“say-on-pay”); and (4) approved, the frequency for an advisory vote of future say-on-pay votes on an annual basis.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523280656/0001193125-23-280656-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}